Strategy meets Execution

Commercial growth and European execution for MedTech, Pharma and Life Sciences.

Q22 helps MedTech, Pharma and Life Sciences companies enter markets, build partnerships and turn commercial ambition into traction.

I support founders, investors and international growth companies with European market entry, interim business development, strategic partnerships, licensing, funding preparation and hands on commercial execution.

Commerciële groei en Europese executie voor MedTech, Pharma en Life Sciences.

Q22 helpt MedTech, Pharma en Life Sciences bedrijven om markten te betreden, partnerships op te bouwen en commerciële ambitie om te zetten in tractie.

Ik ondersteun founders, investeerders en internationale groeibedrijven met Europese markttoegang, interim business development, strategische partnerships, licensing, fundingvoorbereiding en praktische commerciële uitvoering.

€7M+ Funding Raised Funding Opgehaald
2 Concepts to Patient Concepten naar patiënt
20+ Yrs Experience Ervaring

Built on experience across leading healthcare, pharma and life sciences organisations

Gebouwd op ervaring bij toonaangevende organisaties in healthcare, pharma en life sciences

Allergan AstraZeneca DSM-Firmenich Johnson & Johnson Merz Pharma Novartis Nutricia

How Q22 can help

Waarmee kan Q22 helpen?

From strategy to traction

Van strategie naar tractie

Many companies have strong technology, but struggle to turn it into customers, partners, funding or market access.

Veel bedrijven hebben sterke technologie, maar moeite om dit te vertalen naar klanten, partners, funding of markttoegang.

The challenge is often not the product itself. The challenge is focus, positioning, execution and access to the right people.

Het probleem zit vaak niet in het product zelf. Het probleem zit in focus, positionering, uitvoering en toegang tot de juiste mensen.

Q22 helps bridge that gap. I combine senior commercial experience with hands-on execution, so plans move into real conversations, partnerships and market traction.

Q22 helpt om die brug te slaan. Ik combineer senior commerciële ervaring met een hands-on aanpak, zodat plannen worden omgezet in gesprekken, partnerships en markttractie.

Discuss your next step → Bespreek je volgende stap →

Strategy + Execution

Built for companies that need commercial progress

Gebouwd voor bedrijven die commerciële voortgang nodig hebben

Q22 is relevant for:

Q22 is relevant voor:

  • MedTech companies entering or scaling in Europe
  • Pharma and biotech companies building partnerships or market access routes
  • Life Sciences companies commercialising technology, services or platforms
  • Start-ups preparing for funding, licensing or first market traction
  • Scale-ups needing senior commercial execution without hiring immediately
  • International companies looking for trusted European partners
  • Investors validating commercial potential, market entry or partner strategy

Services

Q22 supports companies where commercial strategy needs to become real progress. The work is practical, senior and focused on movement, finding the right market, the right partners and the right next steps. Q22 ondersteunt bedrijven op het punt waar commerciële strategie moet worden omgezet in echte voortgang. Het werk is praktisch, senior en gericht op beweging, de juiste markt en de juiste partners.

EU Market Entry

For international MedTech, Pharma and Life Sciences companies that want to enter or expand in Europe.

Voor internationale MedTech, Pharma en Life Sciences bedrijven die de Europese markt willen betreden of hierin willen uitbreiden.

Key Questions Q22 Helps Answer

  • • Which countries should we prioritise?
  • • Who are the right stakeholders?
  • • What is the strongest proposition?
  • • What operational setup is needed?

What I help with

  • • European market entry strategy
  • • Partner and distributor mapping
  • • Commercial setup and market focus
  • • Regulatory and quality route mapping
  • • Logistics, repair and invoicing flow design
  • • First commercial introductions

Deliverables

  • • EU Entry Roadmap
  • • Country and segment prioritisation
  • • Partner Shortlist
  • • Commercial setup plan
  • • Operational Route-to-Market
Discuss European Market Entry Bespreek EU Market Entry

Interim Business Development

For companies that need senior commercial execution without hiring a full-time business development team immediately.

Voor bedrijven die senior commerciële executie nodig hebben zonder direct een fulltime team aan te nemen.

What I help with

  • • Building a qualified pipeline
  • • Opening strategic accounts
  • • Approaching customers and partners
  • • Creating value propositions
  • • Preparing and leading meetings
  • • Structuring follow-up and deals

Deliverables

  • • Target account list
  • • Partner and customer pipeline
  • • Outreach approach and pitch
  • • Deal progression overview
Explore Interim Support → Verken Interim Support →

Partnerships & Licensing

Finding, approaching and structuring licensing, distribution, CDMO and commercial partnerships.

Het vinden, benaderen en structureren van licensing, distributie, CDMO en commerciële partnerships.

Find the right partners

Start-up & Scale-up Support

From concept, IP and funding preparation to commercial strategy and market execution.

Van concept, IP en fundingvoorbereiding naar commerciële strategie en marktuitvoering.

Prepare your venture

Commercial Positioning

Turning complex technology into a clear value story for customers, partners and investors.

Complexe technologie vertalen naar een duidelijke propositie voor klanten, partners en investeerders.

Sharpen your proposition

Operational Partner Setup

Access trusted partners for legal, regulatory, quality, logistics, repair, returns and administration.

Toegang tot betrouwbare partners voor legal, regulatory, quality, logistiek en administratie.

Build your European setup

Built on real healthcare and Life Sciences experience

€7M+

Funding Raised

2

Concepts to Patient

GMP

Pharma Lab Built

20+ Yrs

Experience

Q22 is built on more than 20 years of commercial and strategic experience across healthcare, pharma, MedTech, medical nutrition, ingredient technologies and Life Sciences. Experience ranges from funding processes and building GMP certified labs to market access and home-based care coordination.

Senior support, practical execution

01

Clarify the real objective

Defining what needs to happen commercially, strategically or operationally to move from ambition to traction.

02

Define the route

Mapping target countries, partners, stakeholders and operational requirements for a realistic route to market.

03

Build the assets

Creating the necessary tools, pitch narratives, partner profiles and market entry roadmaps to engage the market.

04

Execute

Q22 is not only advisory. I actively support outreach, introductions, meetings, and deal progression.

Ivo Schefman

About Q22

Q22 was founded by Ivo Schefman, a senior commercial operator with more than 20 years of experience across healthcare, pharma, MedTech, medical nutrition, ingredient technologies and Life Sciences.

Ivo has worked across sales, market access, business development, licensing, funding, healthcare at home and venture building. His strength lies in connecting strategy with practical execution, bringing the right people together and moving opportunities forward.

Get in touch

Let's discuss your next step

Laten we je volgende stap bespreken

Are you building, scaling or entering Europe in MedTech, Pharma, Life Sciences or healthcare? Q22 helps you move from ambition to execution.

Contact

Ivo Schefman

Q22 | Maastricht, The Netherlands

ivo@q22.eu